GLUTATHIONE-S-TRANSFERASE IN CHEMOTHERAPY RESISTANCE AND IN CARCINOGENESIS

被引:54
作者
SCHECHTER, RL
ALAOUIJAMALI, MA
BATIST, G
机构
[1] MCGILL UNIV,MONTREAL GEN HOSP,RES INST,DEPT MED,1650 CEDAR ST,MONTREAL H3G 1A4,QUEBEC,CANADA
[2] MCGILL UNIV,DEPT ONCOL,MONTREAL H3A 2T5,QUEBEC,CANADA
来源
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE | 1992年 / 70卷 / 05期
关键词
GLUTATHIONE S-TRANSFERASE; CHEMOTHERAPY; CARCINOGENESIS; ALKYLATING AGENTS; DNA DAMAGE;
D O I
10.1139/o92-054
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytosolic glutathione S-transferases are composed of two monomeric subunits. These monomers are the products of different gene families designated alpha, mu, and pi. Dimerization yields either homodimeric or heterodimeric holo-enzymes within the same family. The members of this complex group of proteins have been finked to the detoxification of environmental chemicals and carcinogens, and have been shown to be overexpressed in normal and tumor cells following exposure to cytotoxic drugs. They also are overexpressed in carcinogen-induced rat liver preneoplastic nodules in rat liver. In all of these cases, the changes in expression of glutathione S-transferases are paralleled by increased resistance to cytotoxic chemicals. The degree of resistance is related to the substrate specificity of the isozyme. The relationship of the glutathione S-transferase genes to drug resistance has been directly demonstrated by gene transfer studies, where cDNAs encoding the various subunits of glutathione S-transferase have been transfected into a variety of cell types. This review discusses the results of numerous studies that associate resistance to alkylating agents with overexpression of protective detoxifying glutathione S-transferase enzymes.
引用
收藏
页码:349 / 353
页数:5
相关论文
共 32 条
[1]  
ALAOUI-JAMALI M A, 1991, Proceedings of the American Association for Cancer Research Annual Meeting, V32, P359
[2]  
BATIST G, 1986, J BIOL CHEM, V261, P5544
[3]  
BATIST G, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P12
[4]  
BLACK S, 1989, P NATL ACAD SCI USA, V87, P2443
[5]  
BOLTON MG, 1991, CANCER RES, V51, P2410
[6]  
BULLER AL, 1987, MOL PHARMACOL, V31, P575
[7]   TRANSFORMATION OF RAT-LIVER EPITHELIAL-CELLS WITH V-H-RAS OR V-RAF CAUSES EXPRESSION OF MDR-1, GLUTATHIONE-S-TRANSFERASE-P AND INCREASED RESISTANCE TO CYTO-TOXIC CHEMICALS [J].
BURT, RK ;
GARFIELD, S ;
JOHNSON, K ;
THORGEIRSSON, SS .
CARCINOGENESIS, 1988, 9 (12) :2329-2332
[8]  
CLAPPER M L, 1991, Proceedings of the American Association for Cancer Research Annual Meeting, V32, P361
[9]  
Clapper M. L., 1990, J CELL PHARM, V1, P71
[10]   SIMILAR BIOCHEMICAL-CHANGES ASSOCIATED WITH MULTIDRUG RESISTANCE IN HUMAN-BREAST CANCER-CELLS AND CARCINOGEN-INDUCED RESISTANCE TO XENOBIOTICS IN RATS [J].
COWAN, KH ;
BATIST, G ;
TULPULE, A ;
SINHA, BK ;
MYERS, CE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (24) :9328-9332